Hints and tips:
...This month the company appointed Chris Smith, chief executive of Nasdaq-listed Ortho Clinical Diagnostics to chair the board, and David Berry, general partner at healthcare venture capital firm Flagship...
...Diagnostic tests — brain scans and/or lumbar punctures — are required to determine eligibility for treatment. And the drug is not a simple chemical but an antibody, expensive to develop and produce....
...Wise also pointed to Ortho Clinical Diagnostics, which Carlyle spun out of US drugmaker Johnson & Johnson in 2014....
...Contemporary Amperex Technology Co Ltd Sector: BATTERIES / HQ: NINGDE, CHINA China’s dominant maker of batteries for electric vehicles has boomed thanks to growing sales to global customers such as Tesla...
...Trevor Jones, chairman of Simbec, a clinical research company, warns that most consumer health monitors are still a long way short of producing medical-grade information....
...Investments have included the acquisition of Johnson & Johnson’s ortho clinical diagnostics unit, worth about $4bn including debt....
...J&J last week agreed the sale of its ortho-clinical diagnostics unit, which includes blood testing equipment, to Carlyle, the private equity group, for $4.15bn as part of efforts to narrow the group’s focus...
...“We want to be able to give to people that complete diagnostic experience,” he says....
...Deals for Chuck E Cheese, the entertainment-focused restaurant group, and Johnson & Johnson’s ortho-clinical diagnostics unit followed later in the week....
...It didn’t matter; the pre-clinical issuer’s shares more than tripled....
...laboratory work and clinical trials to test their use....
...of the Israeli-based company in May, Jeremy Levin argued that its biological treatment Copaxone was “complex” and that any rival producing a “biosimilar” version should be required to conduct extensive clinical...
...Quest Diagnostic was the standout performer in the S&P 500, jumping 10.9 per cent to $56.50, after the clinical testing company eked out positive earnings on stronger margins, despite falling sales....
...Further opportunities are emerging in e-healthcare, training and clinical research. There are opportunities in the services sector too....
...Namita Panjabi, co-founder, Masala World restaurant chain....
...Some brokers have reduced their coverage of biotech companies in preference for those that produce diagnostic tests or medical devices....
...Combined with new diagnostics, that would help to identify safer, more effectively targeted treatments....
...It has achieved export earnings of over £35 million over three years and has created nine more jobs Fine and Rare Wines London www.frw.co.uk Employees: 36 Fine and Rare Wines Ltd started business in...
...Meanwhile, Mr Dayan has launched a bid for Arkal Filtration Systems Co-operative Agricultural Society, Amiad’s main domestic competitor of the past 40 years....
...as well as clinical effectiveness....
...Andre Ruzycky, vice-president of technology assessment at Ortho-Clinical Diagnostics, said: “SEEDA, SEHTA and Finance South East have demonstrated a new and innovative way to co-ordinate support and funding...
...Analysts at JPMorgan said in a research note that companies with a strong presence in clinical diagnostics would be able to derive the most synergies....
...Analysts at JP Morgan said in a recent research note that companies with a strong presence in clinical diagnostics would be able to derive the most synergies from buying Vision....
...This allows them to be of enormous use in diagnostics, as they can bind to proteins to detect pregnancy, Aids, cancer and numerous other conditions....
International Edition